These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36724452)

  • 1. Factor IXa variants resistant to plasma inhibitors enhance clot formation in vivo.
    Ivanciu L; Arruda VR; Camire RM
    Blood; 2023 Apr; 141(16):2022-2032. PubMed ID: 36724452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective disruption of heparin and antithrombin-mediated regulation of human factor IX.
    Westmark PR; Tanratana P; Sheehan JP
    J Thromb Haemost; 2015 Jun; 13(6):1053-63. PubMed ID: 25851619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B.
    Brandstetter H; Bauer M; Huber R; Lollar P; Bode W
    Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9796-800. PubMed ID: 7568220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: contribution of the serpin-independent mechanism.
    Buyue Y; Misenheimer TM; Sheehan JP
    J Thromb Haemost; 2012 Oct; 10(10):2086-98. PubMed ID: 22905983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between residues 2228-2240 within factor VIIIa C2 domain and factor IXa Gla domain contribute to propagation of clot formation.
    Soeda T; Nogami K; Ogiwara K; Shima M
    Thromb Haemost; 2011 Nov; 106(5):893-900. PubMed ID: 21947241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular models of the procoagulant factor VIIIa-factor IXa complex.
    Autin L; Miteva MA; Lee WH; Mertens K; Radtke KP; Villoutreix BO
    J Thromb Haemost; 2005 Sep; 3(9):2044-56. PubMed ID: 16102111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulant Protein S Targets the Factor IXa Heparin-Binding Exosite to Prevent Thrombosis.
    Plautz WE; Sekhar Pilli VS; Cooley BC; Chattopadhyay R; Westmark PR; Getz T; Paul D; Bergmeier W; Sheehan JP; Majumder R
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):816-828. PubMed ID: 29419409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maturation of coagulation factor IX during Xase formation as deduced using factor VIII-derived peptides.
    Fang H; Zögg T; Brandstetter H
    FEBS Open Bio; 2019 Aug; 9(8):1370-1378. PubMed ID: 31077577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of the NH2-terminal EGF-domain of factor IXa to the specificity of intrinsic tenase.
    Qureshi SH; Yang L; Rezaie AR
    Thromb Haemost; 2012 Dec; 108(6):1154-64. PubMed ID: 23014580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of coagulation factor IXa to procoagulant platelets revisited: Low affinity and interactions with other factors.
    Soloveva PA; Podoplelova NA; Panteleev MA
    Biochem Biophys Res Commun; 2024 Aug; 720():150099. PubMed ID: 38749192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogen-Deuterium Exchange Mass Spectrometry Identifies Activated Factor IX-Induced molecular Changes in Activated Factor VIII.
    van Galen J; Freato N; Przeradzka MA; Ebberink EHTM; Boon-Spijker M; van der Zwaan C; van den Biggelaar M; Meijer AB
    Thromb Haemost; 2021 May; 121(5):594-602. PubMed ID: 33302303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural insights into the interaction of blood coagulation co-factor VIIIa with factor IXa: a computational protein-protein docking and molecular dynamics refinement study.
    Venkateswarlu D
    Biochem Biophys Res Commun; 2014 Sep; 452(3):408-14. PubMed ID: 25157807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated Plasma Factor IXa Activity in Premenopausal Women on Hormonal Contraception.
    Tanratana P; Ellery P; Westmark P; Mast AE; Sheehan JP
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):266-274. PubMed ID: 29097362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosite occupation by heparin enhances the reactivity of blood coagulation factor IXa.
    Neuenschwander PF
    Biochemistry; 2004 Mar; 43(10):2978-86. PubMed ID: 15005634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emicizumab, the bispecific antibody to factors IX/IXa and X/Xa, potentiates coagulation function in factor XI-deficient plasma in vitro.
    Minami H; Nogami K; Yada K; Ogiwara K; Furukawa S; Soeda T; Kitazawa T; Shima M
    J Thromb Haemost; 2019 Jan; 17(1):126-137. PubMed ID: 30444568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of seminal factor IX and factor IXa in fertile, nonfertile, and vasectomy subjects: a step closer toward identifying a functional clotting system in human semen.
    Lwaleed BA; Greenfield RS; Hicks J; Birch BR; Cooper AJ
    J Androl; 2005; 26(1):146-52. PubMed ID: 15611579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Na+ site in blood coagulation factor IXa: effect on catalysis and factor VIIIa binding.
    Schmidt AE; Stewart JE; Mathur A; Krishnaswamy S; Bajaj SP
    J Mol Biol; 2005 Jul; 350(1):78-91. PubMed ID: 15913649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model for the factor VIIIa-dependent decay of the intrinsic factor Xase. Role of subunit dissociation and factor IXa-catalyzed proteolysis.
    Fay PJ; Beattie TL; Regan LM; O'Brien LM; Kaufman RJ
    J Biol Chem; 1996 Mar; 271(11):6027-32. PubMed ID: 8626386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor VIII-driven changes in activated factor IX explored by hydrogen-deuterium exchange mass spectrometry.
    Freato N; Ebberink EHTM; van Galen J; Fribourg C; Boon-Spijker M; van Alphen FPJ; Meijer AB; van den Biggelaar M; Mertens K
    Blood; 2020 Dec; 136(23):2703-2714. PubMed ID: 32678887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cirrhosis patients have a coagulopathy that is associated with decreased clot formation capacity.
    Kleinegris MC; Bos MH; Roest M; Henskens Y; Ten Cate-Hoek A; Van Deursen C; Spronk HM; Reitsma PH; De Groot PG; Ten Cate H; Koek G
    J Thromb Haemost; 2014 Oct; 12(10):1647-57. PubMed ID: 25142532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.